Deferoxamine: Effective Iron Chelation Therapy for Iron Overload

Summary of Key Points

Deferoxamine is a medication used to treat conditions related to iron overload, such as hemochromatosis, thalassemia, and chronic anemia. It works by binding to excess iron in the body, allowing it to be removed through a process called iron chelation therapy. Deferoxamine is typically administered via injection or infusion. It is essential to follow your healthcare provider’s instructions and consult them before making any changes to your treatment plan.

Names of Medication

US Brand Name: Desferal (Deferoxamine)

The generic name refers to the active ingredient in the medication, which remains consistent across all brands containing this ingredient.

Pharmacologic Category

Iron Chelating Agent

Other medications in this category include: Deferasirox, Deferiprone

Dosing for Deferoxamine

Deferoxamine is used to treat various conditions related to iron overload. The dosage depends on the specific condition being treated. Always consult your healthcare provider before adjusting your dose. You can also schedule a telemedicine appointment with one of our providers for personalized guidance.

Iron Overload (Chronic Iron Toxicity)

Adults: 500 mg to 1,000 mg injected intramuscularly or intravenously, 2 to 6 times per week, depending on the severity of iron overload. The duration of treatment varies based on iron levels and response to therapy.

Hemochromatosis

Adults: 500 mg to 1,000 mg injected intramuscularly or intravenously, 2 to 6 times per week. The length of treatment depends on iron levels and patient response.

Thalassemia (Transfusion-Dependent)

Adults: 20 to 40 mg/kg/day administered subcutaneously over 8 to 12 hours, 5 to 7 days per week. Treatment is ongoing and may be lifelong.

Sickle Cell Disease

Adults: 20 to 40 mg/kg/day administered subcutaneously over 8 to 12 hours, 5 to 7 days per week. The duration of treatment depends on iron levels and response to therapy.

Chronic Anemia

Adults: 20 to 40 mg/kg/day administered subcutaneously over 8 to 12 hours, 5 to 7 days per week. The length of treatment is based on iron levels and patient response.

Beta-Thalassemia

Adults: 20 to 40 mg/kg/day administered subcutaneously over 8 to 12 hours, 5 to 7 days per week. Treatment is typically long-term.

Myelodysplastic Syndromes

Adults: 20 to 40 mg/kg/day administered subcutaneously over 8 to 12 hours, 5 to 7 days per week. The duration of treatment is based on iron levels and patient response.

Chronic Liver Disease (Iron Overload)

Adults: 500 mg to 1,000 mg injected intramuscularly or intravenously, 2 to 6 times per week. The length of treatment depends on iron levels and patient response.

Hemolytic Anemia

Adults: 20 to 40 mg/kg/day administered subcutaneously over 8 to 12 hours, 5 to 7 days per week. The duration of treatment is based on iron levels and patient response.

Transfusion-Related Hemosiderosis

Adults: 20 to 40 mg/kg/day administered subcutaneously over 8 to 12 hours, 5 to 7 days per week. Treatment is typically long-term.

Dosage Forms and Strengths

Deferoxamine is available in the following forms:

1. Intramuscular injection: 500 mg vial
2. Intravenous infusion: 500 mg vial
3. Subcutaneous infusion: 500 mg vial

Administration Instructions for Deferoxamine

Deferoxamine is typically administered via injection or infusion. It can be given intramuscularly, intravenously, or subcutaneously, depending on your condition and your healthcare provider’s recommendation. If you are administering the medication at home, your healthcare provider will provide detailed instructions on how to prepare and administer it. Always follow these instructions carefully, and if you have any questions, reach out to your healthcare provider or schedule a telemedicine consultation with us.

Contraindications for Deferoxamine

A contraindication is a specific situation or condition where a medication should not be used because it may be harmful. Before starting any new medication, it’s important to understand if there are any contraindications that apply to you. Below are the contraindications for taking Deferoxamine:

1. Severe kidney disease: Deferoxamine is processed by the kidneys. If your kidneys are not functioning properly, the medication may not be cleared from your body, leading to toxic levels.
2. Allergy to Deferoxamine: If you have a known allergy to Deferoxamine, taking the medication could trigger a severe allergic reaction, which can be life-threatening.
3. Pregnancy (unless absolutely necessary): Deferoxamine is generally avoided during pregnancy unless the benefits outweigh the risks. It may affect fetal development (discussed in more detail below).
4. Severe lung disease: Deferoxamine can cause lung complications, especially in individuals with pre-existing lung conditions. It may worsen respiratory symptoms.

If you have any of these conditions, it’s critical to discuss them with your healthcare provider before starting Deferoxamine. You can also schedule a telemedicine appointment with one of our providers to discuss your options.

Drug-to-Drug Interactions

Deferoxamine can interact with other medications, which may either reduce its effectiveness or increase the risk of side effects. Below are some medications that interact with Deferoxamine:

1. Prochlorperazine (Compazine): This medication, used to treat nausea and vomiting, can increase the risk of neurological side effects when taken with Deferoxamine.
2. Vitamin C (Ascorbic Acid): High doses of Vitamin C can enhance the effects of Deferoxamine, potentially leading to heart problems. If you need to take Vitamin C, it should be done under close medical supervision.
3. Gallium nitrate (Ganite): This medication, used to treat high calcium levels, may increase the risk of kidney damage when taken with Deferoxamine.

Always inform your healthcare provider about all the medications and supplements you are taking. If you’re unsure, one of our telemedicine providers can help you review your medication list.

Deferoxamine in Pregnancy

Is it safe to take Deferoxamine when pregnant?

Deferoxamine, an iron chelator, is classified as a pregnancy category C drug by the FDA. This classification means that while there are no well-controlled studies in humans, animal studies have shown potential risks to the fetus. Deferoxamine should only be used during pregnancy if the potential benefits outweigh the risks. If you are pregnant or planning to become pregnant, it is important to consult your healthcare provider to discuss whether Deferoxamine is appropriate for your situation. You can also schedule a telemedicine consultation with one of our providers to explore your options for iron chelation therapy during pregnancy.

Deferoxamine while Breastfeeding

Is it safe to take Deferoxamine while breastfeeding?

The safety of Deferoxamine during breastfeeding has not been well established. It is unclear whether Deferoxamine passes into breast milk, and there may be potential risks to a nursing infant. If you are breastfeeding or planning to breastfeed, it is essential to discuss the risks and benefits of using Deferoxamine with your healthcare provider. Our telemedicine providers are available to help you make an informed decision regarding iron chelation therapy while breastfeeding.

Estimated Cost of Deferoxamine Medication

The cost of Deferoxamine can vary depending on your location and the pharmacy you use. Without insurance, the estimated cost of a 30-day supply of Deferoxamine using a GoodRx coupon ranges from approximately $1,200 to $1,500. For the most accurate pricing, check with your pharmacy, and consider discussing financial assistance options with your healthcare provider. If you are undergoing iron chelation therapy, it’s important to explore all available financial resources to help manage the cost of Deferoxamine treatment.

Possible Alternatives to Deferoxamine

If Deferoxamine is not suitable for you, alternative treatments or lifestyle changes may help manage your condition. Always consult your healthcare provider before making any changes to your treatment plan. Below are some alternatives based on specific conditions:

1. Iron overload: Other iron chelators, such as Deferasirox (Exjade) or Deferiprone (Ferriprox), may be considered. Reducing dietary iron intake and avoiding iron supplements can also be beneficial.
2. Hemochromatosis: Phlebotomy (regular blood removal) is a common alternative to remove excess iron. Lifestyle changes, such as avoiding alcohol and iron-rich foods, may also be recommended.
3. Thalassemia: Blood transfusions and folic acid supplements are often used. In some cases, bone marrow transplants may be considered.
4. Sickle cell disease: Hydroxyurea (Droxia) is commonly prescribed to reduce pain episodes. Blood transfusions and lifestyle changes, such as staying hydrated, can also help manage symptoms.
5. Chronic anemia: Erythropoiesis-stimulating agents (ESAs) like Epoetin alfa (Epogen) may be used. Iron supplements or dietary changes may also help if anemia is due to iron deficiency.
6. Beta-thalassemia: Regular blood transfusions and iron chelation therapy are standard treatments. In some cases, gene therapy is being explored as a potential cure.
7. Myelodysplastic syndromes: Treatment may include blood transfusions, medications like Lenalidomide (Revlimid), or bone marrow transplants.
8. Chronic liver disease: Managing the underlying cause of liver disease is key. Lifestyle changes, such as avoiding alcohol and maintaining a healthy diet, can help protect liver function.
9. Hemolytic anemia: Treatment may include corticosteroids, immunosuppressive drugs, or blood transfusions, depending on the cause.
10. Transfusion-related hemosiderosis: Iron chelation therapy with medications like Deferasirox (Exjade) or Deferiprone (Ferriprox) may be used to manage iron overload from frequent transfusions.

It’s important to discuss these alternatives with your healthcare provider to determine the best course of action for your specific condition. You can schedule a telemedicine appointment with one of our providers to explore these options in more detail, especially if you are considering alternatives to Deferoxamine for iron chelation therapy.

Recent Updates on Deferoxamine Research

Recent research on Deferoxamine has expanded beyond its traditional use in treating iron overload conditions. Studies are now exploring its potential neuroprotective effects, particularly in conditions like Alzheimer’s disease and traumatic brain injury. Early findings suggest that Deferoxamine may help reduce oxidative stress and inflammation in the brain, potentially slowing the progression of neurodegenerative diseases. However, more research is needed to confirm these benefits in humans.

Additionally, ongoing studies are investigating the use of Deferoxamine in treating certain cancers. By limiting the availability of iron, which cancer cells need to grow, Deferoxamine may help inhibit tumor growth. These studies are still in the early stages, and Deferoxamine is not yet approved for these uses.

If you are interested in learning more about these developments or participating in clinical trials, consult your healthcare provider. Our telemedicine providers can also help you stay informed about the latest research and how it might impact your treatment plan, especially if you are undergoing Deferoxamine treatment for iron overload or other conditions.

James Kingsley

Learn More